Literature DB >> 1189982

The risk of atherosclerotic vascular disease in subjects with xanthomatosis.

A Heiberg.   

Abstract

The morbidity and mortality in 172 males and 164 females with xanthomatosis have been investigated. Symptoms of coronary heart disease (CHD) were the most frequent initial manifestation of atherosclerotic vascular disease. Angina pectoris was the first symptom in about 3/4 of males as well as females; myocardial infarction was the first event in 26% of the males and 9% of the females. Other manifestations of atherosclerosis were comparatively rare and occurred late in life. Half of the subjects were affected with symptoms of atherosclerotic vascular disease by the age of 52 in men and 62 in women, the mean age for first symptoms being 49 and 56 years, respectively. No significant influence of other CHD risk factors than xanthomatosis and hyperlipidaemia was found in these patients. An increase in the number of cardiovascular deaths was seen in xanthomatosis patients, compared with the general population, in particular in the number of "sudden deaths". Half of the males died before the age of 66 and half of the females before the age of 74.5, which is about 10 and 7 years earlier than predicted at 30 years of age for the normal population. The cumulative relative mortality in both men and women was about twice that expected for the general Norwegian population until 70 years of age.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1189982     DOI: 10.1111/j.0954-6820.1975.tb19536.x

Source DB:  PubMed          Journal:  Acta Med Scand        ISSN: 0001-6101


  8 in total

1.  Family similarities in the age at coronary death in familial hypercholesterolaemia.

Authors:  A Heiberg; J Slack
Journal:  Br Med J       Date:  1977-08-20

2. 

Authors:  Th Wichmann; H -A Freye; K Berndt
Journal:  Hum Genet       Date:  1981-05       Impact factor: 4.132

3.  Risk of fatal coronary heart disease in familial hypercholesterolaemia. Scientific Steering Committee on behalf of the Simon Broome Register Group.

Authors: 
Journal:  BMJ       Date:  1991-10-12

4.  Cardiovascular risk in patients with treated familial hypercholesterolaemia and patients with severe hypertriglyceridaemia.

Authors:  B P Way; M J Ball; M Thorogood; S M Cobbe; J I Mann
Journal:  J R Soc Med       Date:  1986-07       Impact factor: 5.344

5.  Cross sectional echocardiographic assessment of the aortic root and coronary ostial stenosis in familial hypercholesterolaemia.

Authors:  P Ribeiro; L M Shapiro; A Gonzalez; G R Thompson; C M Oakley
Journal:  Br Heart J       Date:  1983-11

6.  Contrasting patterns of coronary atherosclerosis in normocholesterolaemic smokers and patients with familial hypercholesterolaemia.

Authors:  D D Sugrue; G R Thompson; C M Oakley; I M Trayner; R E Steiner
Journal:  Br Med J (Clin Res Ed)       Date:  1981-11-21

7.  Screening for hyperlipidaemia in childhood. Recommendations of the British Hyperlipidaemia Association.

Authors:  R Wray; H Neil; J Rees
Journal:  J R Coll Physicians Lond       Date:  1996 Mar-Apr

8.  Enhanced status of inflammation and endothelial activation in subjects with familial hypercholesterolaemia and their related unaffected family members: a case control study.

Authors:  Thuhairah Rahman; Nur Suhana Hamzan; Atiqah Mokhsin; Radzi Rahmat; Zubin Othman Ibrahim; Rafezah Razali; Malathi Thevarajah; Hapizah Nawawi
Journal:  Lipids Health Dis       Date:  2017-04-24       Impact factor: 3.876

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.